Correlation Between Terns Pharmaceuticals and Histogen
Can any of the company-specific risk be diversified away by investing in both Terns Pharmaceuticals and Histogen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Terns Pharmaceuticals and Histogen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Terns Pharmaceuticals and Histogen, you can compare the effects of market volatilities on Terns Pharmaceuticals and Histogen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Terns Pharmaceuticals with a short position of Histogen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Terns Pharmaceuticals and Histogen.
Diversification Opportunities for Terns Pharmaceuticals and Histogen
0.17 | Correlation Coefficient |
Average diversification
The 3 months correlation between Terns and Histogen is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Terns Pharmaceuticals and Histogen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Histogen and Terns Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Terns Pharmaceuticals are associated (or correlated) with Histogen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Histogen has no effect on the direction of Terns Pharmaceuticals i.e., Terns Pharmaceuticals and Histogen go up and down completely randomly.
Pair Corralation between Terns Pharmaceuticals and Histogen
Given the investment horizon of 90 days Terns Pharmaceuticals is expected to generate 4.38 times less return on investment than Histogen. But when comparing it to its historical volatility, Terns Pharmaceuticals is 3.01 times less risky than Histogen. It trades about 0.02 of its potential returns per unit of risk. Histogen is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 31.00 in Histogen on August 25, 2024 and sell it today you would lose (29.00) from holding Histogen or give up 93.55% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Terns Pharmaceuticals vs. Histogen
Performance |
| Timeline |
| Terns Pharmaceuticals |
| Histogen |
Terns Pharmaceuticals and Histogen Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Terns Pharmaceuticals and Histogen
The main advantage of trading using opposite Terns Pharmaceuticals and Histogen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Terns Pharmaceuticals position performs unexpectedly, Histogen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Histogen will offset losses from the drop in Histogen's long position.| Terns Pharmaceuticals vs. Capricor Therapeutics | Terns Pharmaceuticals vs. Akari Therapeutics PLC | Terns Pharmaceuticals vs. Soleno Therapeutics | Terns Pharmaceuticals vs. Bio Path Holdings |
| Histogen vs. Virax Biolabs Group | Histogen vs. Altamira Therapeutics | Histogen vs. Aileron Therapeutics | Histogen vs. Artelo Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |